ADMA Biologics, Inc.
ADMA
$17.02
$0.110.65%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.80% | 30.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.80% | 30.92% | |||
| Cost of Revenue | 20.99% | 16.30% | |||
| Gross Profit | 3.84% | 46.91% | |||
| SG&A Expenses | 11.57% | 5.44% | |||
| Depreciation & Amortization | -80.28% | -26.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.96% | 13.21% | |||
| Operating Income | 1.11% | 79.65% | |||
| Income Before Tax | 2.50% | 94.83% | |||
| Income Tax Expenses | -77.83% | 536.81% | |||
| Earnings from Continuing Operations | 12.00% | 80.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.00% | 80.06% | |||
| EBIT | 1.11% | 79.65% | |||
| EBITDA | 0.80% | 72.33% | |||
| EPS Basic | 11.02% | 77.25% | |||
| Normalized Basic EPS | 1.56% | 92.03% | |||
| EPS Diluted | 15.38% | 67.10% | |||
| Normalized Diluted EPS | 1.41% | 90.33% | |||
| Average Basic Shares Outstanding | 0.93% | 1.55% | |||
| Average Diluted Shares Outstanding | 1.09% | 2.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
